Adagene Change To Inventory from 2010 to 2026

ADAG Stock  USD 2.77  0.28  11.24%   
Adagene's Change To Inventory is increasing over the last several years with slightly volatile swings. Change To Inventory is estimated to finish at about 7.3 M this year. Change To Inventory is the increase or decrease in the amount of inventory Adagene has over a certain period. View All Fundamentals
 
Change To Inventory  
First Reported
2010-12-31
Previous Quarter
6.9 M
Current Value
7.3 M
Quarterly Volatility
4.3 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Adagene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Adagene's main balance sheet or income statement drivers, such as Net Interest Income of 3.6 M, Interest Income of 4.6 M or Depreciation And Amortization of 1.1 M, as well as many indicators such as Price To Sales Ratio of 767, Dividend Yield of 0.0 or PTB Ratio of 1.34. Adagene financial statements analysis is a perfect complement when working with Adagene Valuation or Volatility modules.
  
Build AI portfolio with Adagene Stock
Check out the analysis of Adagene Correlation against competitors.
For more detail on how to invest in Adagene Stock please use our How to Invest in Adagene guide.

Latest Adagene's Change To Inventory Growth Pattern

Below is the plot of the Change To Inventory of Adagene over the last few years. It is the increase or decrease in the amount of inventory a company has over a certain period. Adagene's Change To Inventory historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Adagene's overall financial position and show how it may be relating to other accounts over time.
Change To Inventory10 Years Trend
Slightly volatile
   Change To Inventory   
       Timeline  

Adagene Change To Inventory Regression Statistics

Arithmetic Mean783,218
Geometric Mean3,342,980
Coefficient Of Variation555.32
Mean Deviation3,963,359
Median(2,585,637)
Standard Deviation4,349,397
Sample Variance18.9T
Range9.8M
R-Value0.87
Mean Square Error4.8T
R-Squared0.76
Slope752,879
Total Sum of Squares302.7T

Adagene Change To Inventory History

20267.3 M
20256.9 M
2021M
2020925.2 K

About Adagene Financial Statements

Adagene stakeholders use historical fundamental indicators, such as Adagene's Change To Inventory, to determine how well the company is positioned to perform in the future. Although Adagene investors may analyze each financial statement separately, they are all interrelated. For example, changes in Adagene's assets and liabilities are reflected in the revenues and expenses on Adagene's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Adagene. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Change To Inventory6.9 M7.3 M

Currently Active Assets on Macroaxis

When determining whether Adagene is a strong investment it is important to analyze Adagene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adagene's future performance. For an informed investment choice regarding Adagene Stock, refer to the following important reports:
Check out the analysis of Adagene Correlation against competitors.
For more detail on how to invest in Adagene Stock please use our How to Invest in Adagene guide.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Can Biotechnology industry sustain growth momentum? Does Adagene have expansion opportunities? Factors like these will boost the valuation of Adagene. If investors know Adagene will grow in the future, the company's valuation will be higher. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Adagene demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share
(0.64)
Revenue Per Share
0.002
Quarterly Revenue Growth
(0.87)
Return On Assets
(0.25)
Return On Equity
(0.63)
The market value of Adagene is measured differently than its book value, which is the value of Adagene that is recorded on the company's balance sheet. Investors also form their own opinion of Adagene's value that differs from its market value or its book value, called intrinsic value, which is Adagene's true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because Adagene's market value can be influenced by many factors that don't directly affect Adagene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Adagene's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Adagene represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Adagene's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.